P1.163. Early Postoperative Pain Trajectory Phenotypes After Oesophagectomy Within a Multimodal Analgesia Pathway

Clicks: 22
ID: 325943
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #93 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background Postoperative pain after oesophagectomy remains heterogeneous despite multimodal analgesia. Identifying early pain trajectory phenotypes may help recognise patients who require targeted analgesic escalation. We derived postoperative day 1–5 pain trajectory phenotypes and assessed associations with length of stay and readmission. Methods Consecutive oesophagectomy patients managed within a multimodal analgesia pathway were reviewed. Maximum daily pain scores were recorded contemporaneously. Patients with complete overall pain scores (0–10 NRS) recorded on postoperative days (POD) 1–5 were included; for each POD the maximum recorded overall score was used. Pain trajectory phenotypes were identified using k-means clustering (k=3) applied to z-standardised POD1–5 pain profiles, using multiple random initialisations and retaining the solution with the lowest within-cluster sum of squares. Phenotypes were summarised using, peak daily pain (maximum POD1–5), and pain burden quantified by area-under-the-curve (AUC) across POD1–5. Total length of stay (LOS) was compared across phenotypes using Kruskal–Wallis testing. Readmission rates were compared using chi-square testing. Results Consecutive oesophagectomy patients managed within a multimodal analgesia pathway were reviewed. Maximum daily pain scores were recorded contemporaneously. Patients with complete overall pain scores (0–10 NRS) recorded on postoperative days (POD) 1–5 were included; for each POD the maximum recorded overall score was used. Pain trajectory phenotypes were identified using k-means clustering (k=3) applied to z-standardised POD1–5 pain profiles, using multiple random initialisations and retaining the solution with the lowest within-cluster sum of squares. Phenotypes were summarised using, peak daily pain (maximum POD1–5), and pain burden quantified by area-under-the-curve (AUC) across POD1–5. Total length of stay (LOS) was compared across phenotypes using Kruskal–Wallis testing. Readmission rates were compared using chi-square testing. Conclusion Despite multimodal analgesia, nearly one in five patients demonstrated a persistent-high pain trajectory through POD5, with substantially greater peak pain and overall pain burden than low and moderate trajectories. However, pain phenotype was not associated with total LOS or readmission in this cohort. Trajectory phenotyping captures clinically meaningful heterogeneity beyond single-day comparisons and may still support targeted analgesic escalation; future work should link phenotypes to opioid use, mobilisation, complications and patient-reported outcomes.
Reference Key
openalex_W7204001657 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.311
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.